These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Optimisation of aciclovir poly(D,L-lactide-co-glycolide) microspheres for intravitreal administration using a factorial design study.
    Author: Martínez-Sancho C, Herrero-Vanrell R, Negro S.
    Journal: Int J Pharm; 2004 Apr 01; 273(1-2):45-56. PubMed ID: 15010129.
    Abstract:
    The purpose of this work was to obtain an optimised long-term aciclovir PLGA microspheres formulation for intravitreal administration to minimise, as much as possible, the dose of microspheres to be administered with a suitable particle size for its injection through a 27G needle in a single dose. Microspheres were prepared by the solvent evaporation method. To obtain the optimum formulation a two-factor five-level central rotatable composite 2(2) + star design was employed. The independent variables were aciclovir and gelatin (added to the external phase of the emulsion). The dependent variables were the yield of production (%), the encapsulation efficiency (%), the initial burst release (%), the cumulative amount released from 1 to 14 days and the amount of aciclovir at the end of the release assay (microg aciclovir/mg microspheres). The best formulation according to the studied variables was (0,0), prepared with 80 mg of aciclovir and 80 mg of gelatin. This formulation showed good yield of production (70.14 +/- 3.72 %) and encapsulation efficiency ( 70.77 +/- 2.62 %), and released the drug at a constant rate for 63 days with a mean release constant of 1.73 +/- 0.08 microg/day per mg microspheres. The selected formulation reduces a 40% the dose of microspheres to be administered through a 27G needle with respect to previous studies.
    [Abstract] [Full Text] [Related] [New Search]